Drug Information

Drug General Information
Drug ID
D0U0EM
Former ID
DIB000397
Drug Name
Reformulated raltegravir
Indication Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] Phase 3 [551146]
Company
Merck
Target and Pathway
Target(s) HIV integrase Target Info Modulator [529974]
References
Ref 551146Clinical pipeline report, company report or official report of Merck.
Ref 529974Raltegravir: the first HIV type 1 integrase inhibitor. Clin Infect Dis. 2009 Apr 1;48(7):931-9.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.